MITOBRIDGE INC / ASTELLAS PHARMA INC. / Acquisition / Private / £335m

Synopsis

Tokyo, Japan-based Astellas Pharma Inc. acquired its partner Mitobridge, Inc., a biotechnology company focuses on mitochondrial therapeutics, for up to $450 million.

Principals

target

Mitobridge

bidder

Astellas Pharma

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

morrison & foerster

HQ - San Francisco

legal advisors

bidder

948

Deals

£ 682.15 B

Total Value